Titan Pharmaceuticals Inc
TTNP4.610USD
0.000
종가 11/04, 16:00（ET）시세는 15분 지연됩니다
6.13M시가총액
손실P/E TTM
자세한 내용은 Titan Pharmaceuticals Inc 회사
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.
Titan Pharmaceuticals Inc 정보
종목 코드 TTNP
회사 이름Titan Pharmaceuticals Inc
상장일Jan 18, 1996
CEOMr. Weei Jye Chay
직원 수- -
유형Ordinary Share
회계 연도 종료Jan 18
주소Suite 505
도시SAN FRANCISCO
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호94080
전화14152444990
웹사이트https://www.titanpharm.com/
종목 코드 TTNP
상장일Jan 18, 1996
CEOMr. Weei Jye Chay
Titan Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Weei Jye Chay
Mr. Weei Jye Chay
Company Secretary, Director
Company Secretary, Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Weei Jye Chay
Mr. Weei Jye Chay
Company Secretary, Director
Company Secretary, Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Tue, Oct 28
마지막 업데이트: Tue, Oct 28
주주
주주 유형
주주
주주
비율
Blue Harbour Asset Management L.L.C
19.99%
Choong (Choon Hau)
18.16%
Chung (Jeffrey)
11.28%
Citadel Advisors LLC
0.91%
Renaissance Technologies LLC
0.86%
기타
48.81%
주주
주주
비율
Blue Harbour Asset Management L.L.C
19.99%
Choong (Choon Hau)
18.16%
Chung (Jeffrey)
11.28%
Citadel Advisors LLC
0.91%
Renaissance Technologies LLC
0.86%
기타
48.81%
주주 유형
주주
비율
Individual Investor
29.44%
Corporation
19.99%
Hedge Fund
1.76%
Investment Advisor
1.06%
Investment Advisor/Hedge Fund
0.52%
기타
47.22%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
36
44.54K
3.35%
-16.74K
2025Q2
40
414.53K
44.46%
-42.07K
2025Q1
46
436.25K
42.35%
-38.12K
2024Q4
45
429.27K
46.95%
-32.22K
2024Q3
46
432.62K
47.32%
-13.85K
2024Q2
51
448.01K
49.00%
-8.81K
2024Q1
52
447.94K
49.00%
-53.81K
2023Q4
49
450.14K
59.78%
+330.86K
2023Q3
57
298.19K
41.35%
-95.76K
2023Q2
53
281.88K
39.24%
-113.75K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Blue Harbour Asset Management L.L.C
265.91K
19.99%
+265.91K
--
Jul 18, 2025
Choong (Choon Hau)
241.53K
18.16%
--
--
Jul 18, 2025
Chung (Jeffrey)
150.09K
11.28%
+6.25K
+4.35%
Jul 18, 2025
Citadel Advisors LLC
12.07K
0.91%
+108.00
+0.90%
Jun 30, 2025
Renaissance Technologies LLC
11.38K
0.86%
+11.38K
--
Jun 30, 2025
Marex Group plc
10.66K
0.8%
+10.66K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
6.88K
0.52%
--
--
Aug 31, 2025
UBS Financial Services, Inc.
3.43K
0.26%
+833.00
+32.11%
Jun 30, 2025
Corecap Advisors Inc
88.00
0.01%
--
--
Jun 30, 2025
BofA Global Research (US)
18.00
0%
--
--
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sun, Nov 2
마지막 업데이트: Sun, Nov 2
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Dec 28, 2023
Merger
20→1
Dec 28, 2023
Merger
20→1
Dec 28, 2023
Merger
20→1
Dec 28, 2023
Merger
20→1
Nov 30, 2020
Merger
30→1
Nov 30, 2020
Merger
30→1
날짜
유형
비율
Dec 28, 2023
Merger
20→1
Dec 28, 2023
Merger
20→1
Dec 28, 2023
Merger
20→1
Dec 28, 2023
Merger
20→1
Nov 30, 2020
Merger
30→1
Nov 30, 2020
Merger
30→1
Nov 30, 2020
Merger
30→1
Nov 30, 2020
Merger
30→1
